8,517 articles
Benjamin Wolozin
Benjamin Wolozin is an American physician-scientist and professor at Boston University who studies the cell and molecular biology of neurodegenerative disease, including Alzheimer's disease, ALS, and frontotemporal dementia, and co-founded Aquinnah Pharmaceuticals.
Bennett A. Shaywitz
Bennett A. Shaywitz is an American pediatric neurologist and physician-scientist at Yale School of Medicine whose functional brain-imaging studies helped establish dyslexia as a disorder of brain organization.
Benoit I. Giasson
Benoit I. Giasson is a University of Florida neuroscientist who studies how alpha-synuclein misfolds and spreads in Parkinson's disease, known for a 2000 Science paper linking nitrated alpha-synuclein to synucleinopathy lesions.
Benoît Nemery
Benoît Nemery, full name Benoit Nemery de Bellevaux, is a Belgian physician-scientist in lung toxicology and occupational medicine at KU Leuven, becoming Emeritus Professor in 2018.
Berend Isermann
Berend Isermann, born 1967 in Kiel, is a German physician and clinical chemist who directs the Institute of Laboratory Medicine at Leipzig University Hospital and studies coagulation proteases in vascular disease.
Berge A. Minassian
Berge A. Minassian is a Canadian-trained pediatric neurologist and neurogeneticist, Division Chief of Child Neurology at UT Southwestern, known for discovering the Lafora disease genes and developing gene therapies for childhood neurological diseases.
Berislav V. Zloković
Berislav V. Zloković, also written Berislav Zlokovic, is a neuroscientist and physician at the University of Southern California who showed blood-brain barrier breakdown is an early biomarker of cognitive dysfunction.
Bernadine H. Bulkley
Bernadine H. Bulkley (Bernadine Healy, 1944–2011) was an American cardiologist who, as Bernadine P. Healy, became the first female director of the National Institutes of Health.
Bernadine Healy
Bernadine Healy (1944-2011), American cardiologist and first female NIH director (1991-1993), launched the Women's Health Initiative, led the American Red Cross 9/11 response, and later deaned Ohio State's medical school.
Bernard Brodie (pharmacologist)
Bernard Brodie (1907–1989) was an American pharmacologist who founded and led the Laboratory of Chemical Pharmacology at NIH, and whose work on serotonin and drug metabolism helped found psychopharmacology.
Bernard Chaitman
Bernard R. Chaitman is an American cardiologist at Saint Louis University School of Medicine known for research on ischemic heart disease and exercise stress testing.
Bernard De Bruyne
Bernard De Bruyne is a Belgian interventional cardiologist at the Cardiovascular Center Aalst who developed fractional flow reserve and led the FAME trials showing FFR-guided stenting improves outcomes.
Bernard Escudier
Bernard J. Escudier is a French medical oncologist at Gustave Roussy in Villejuif who led the phase III trials introducing sorafenib, bevacizumab, and nivolumab–ipilimumab into kidney cancer treatment, winning the 2022 ESMO Lifetime Achievement Award.
Bernard G. Forget
Bernard G. Forget (1939–2015) was an American hematologist and geneticist at Yale School of Medicine whose molecular work on thalassemia and globin genes helped found molecular medicine.
Bernard Guyer
Bernard Guyer is an American pediatrician and perinatal epidemiologist, Zanvyl Krieger Professor emeritus at the Johns Hopkins Bloomberg School of Public Health, who published over 300 works on child health.
Bernard Halpern
Bernard Halpern (Naftali Halpern, 1904–1978) was a French pharmacologist and immunologist, born in what is now Ukraine, who discovered the first synthetic antihistamines usable in human medicine, including Antergan and promethazine.
Bernard Hirschel
Bernard Hirschel is a Swiss infectious-diseases physician and HIV researcher, born in 1946, who headed the HIV/AIDS unit of the Geneva University Hospitals from 1989.
Bernard J. Gersh
Bernard J. Gersh (B.J. Gersh) is a South African-born cardiologist who has spent most of his career at the Mayo Clinic, studying atrial fibrillation and coronary disease.
Bernard Kliman
Bernard Kliman was an American endocrinologist at Massachusetts General Hospital and Harvard Medical School, known for the double-isotope aldosterone assay, renin radioimmunoassay, and proton-beam pituitary treatment.
Bernard Lown
Bernard Lown, born Bernard Latz, was a Lithuanian-born American cardiologist at Harvard who developed direct-current defibrillation, established Boston's first coronary care unit, and shared the 1985 Nobel Peace Prize.
Bernard Nordlinger
Bernard Nordlinger is a French surgeon and professor who directed digestive surgery at Hôpital Ambroise Paré and led the EORTC 40983 trial of perioperative FOLFOX4 chemotherapy for colorectal liver metastases.
Bernard Prendergast
Bernard Prendergast is a cardiologist specializing in valvular heart disease and structural intervention, Chair of Cardiology at Cleveland Clinic London and a consultant at St Thomas' Hospital.
Bernard Thorens
Bernard Thorens, born in Geneva in 1955, is a Swiss professor at the University of Lausanne known for cloning GLUT2 and the GLP-1 receptor, a type 2 diabetes drug target.
Bernard Zinman
Bernard Zinman is a Canadian clinician-scientist at the University of Toronto and Mount Sinai Hospital who led the DCCT and EMPA-REG OUTCOME diabetes trials and entered the Canadian Medical Hall of Fame in 2026.
Bernardo Rodríguez‐Iturbe
Bernardo Rodríguez-Iturbe, also known as Bernardo Rodriguez-Iturbe, is a Venezuelan nephrologist at the Hospital Universitario de Maracaibo known for work on poststreptococcal glomerulonephritis and salt-sensitive hypertension.
Bernd Groner
Bernd Groner, born 1946, is a German cancer researcher known for work on Stat5, prolactin signaling, and breast cancer, who directed the Georg Speyer Haus in Frankfurt.
Bernd Schnabl
Bernd Schnabl is a German-trained gastroenterologist and Professor of Medicine at UC San Diego since 2008, known for research on the gut–liver axis and bacteriophage therapy for alcoholic liver disease.
Bernhard Hemmer
Bernhard Hemmer (born 1963) is a German neurologist and neuroimmunologist who has directed neurology at TUM University Hospital in Munich since 2007, specializing in multiple sclerosis.
Bernhard Lauritz Frederik Bang
Bernhard Lauritz Frederik Bang (1848–1932) was a Danish veterinarian and bacteriologist who discovered Brucella abortus, the cause of Bang's disease in cattle, and designed Denmark's bovine tuberculosis eradication program.
Bernhard Meier
Bernhard Meier, born 1950 in Bern, is a Swiss interventional cardiologist who led cardiology at the Inselspital from 1992 to 2015 and ran PFO closure trials.